EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selective MicroRNA Dysregulation in IPF ‐Derived Mesenchymal Stromal Cells Suggests Restricted Regulatory Remodeling

Mariangela Di Vincenzo, Federico Mei, Paride Cavina, Francesca Gonnelli, Martina Bonifazi, Monia Orciani iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202602423rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Mariangela Di Vincenzo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Sciences-Histology, Università Politecnica Delle Marche, Ancona, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Mesenchymal Stem Cells, Idiopathic Pulmonary Fibrosis. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim (Boehringer Ingelheim International GmbH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The schematic workflow illustrates next-generation sequencing of lung-derived mesenchymal stromal cells (MSCs) from IPF patients and controls. Rather than broad epigenetic reprogramming, IPF-MSCs exhibit a remarkably restricted down-regulation of only three critical microRNAs: hsa-miR-373-3p, hsa-miR-486-5p, and hsa-miR-449a. This selective dysregulation leads to the targeted upregulation of key profibrotic genes (SMAD4, BCL2, TGF-β, CXCL12, VEGF), driving TGF-β cascade activation, altered autophagy, and profibrotic and proangiogenic signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMesenchymal Stem CellsIdiopathic Pulmonary FibrosisHumansTransforming Growth Factor betaSignal TransductionAutophagyGene Expression RegulationSmad4 ProteinLung

Substanzen

MicroRNAsTransforming Growth Factor betaMIRN486 microRNA, humanSmad4 Protein

Autor:innen und Institutionen

  • Department of Clinical and Molecular Sciences-Histology, Università Politecnica Delle Marche, Ancona, Italy.
  • Department of Biomedical Sciences and Public Health, Università Politecnica Delle Marche, Ancona, Italy.
  • Interstitial Lung Diseases, Pleural Diseases and Bronchiectasis Unit, AOU Delle Marche, Ancona, Italy.

ORCID-Profile: Monia Orciani

Förderung

  • Boehringer Ingelheim (Boehringer Ingelheim International GmbH)

Zitieren

APA

Di Vincenzo, M., Mei, F., Cavina, P., Gonnelli, F., Bonifazi, M., & Orciani, M. (2026). Selective MicroRNA Dysregulation in IPF ‐Derived Mesenchymal Stromal Cells Suggests Restricted Regulatory Remodeling. The FASEB Journal. https://doi.org/10.1096/fj.202602423rr

Vancouver

Di Vincenzo M, Mei F, Cavina P, Gonnelli F, Bonifazi M, Orciani M. Selective MicroRNA Dysregulation in IPF ‐Derived Mesenchymal Stromal Cells Suggests Restricted Regulatory Remodeling. The FASEB Journal. 2026. doi:10.1096/fj.202602423rr

BibTeX
@article{DiVincenzo2026,
  author = {Di Vincenzo, Mariangela and Mei, Federico and Cavina, Paride and Gonnelli, Francesca and Bonifazi, Martina and Orciani, Monia},
  title = {Selective MicroRNA Dysregulation in IPF ‐Derived Mesenchymal Stromal Cells Suggests Restricted Regulatory Remodeling},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202602423rr}
}
Kostenlos starten →